JP2023133505A5 - - Google Patents

Download PDF

Info

Publication number
JP2023133505A5
JP2023133505A5 JP2023126157A JP2023126157A JP2023133505A5 JP 2023133505 A5 JP2023133505 A5 JP 2023133505A5 JP 2023126157 A JP2023126157 A JP 2023126157A JP 2023126157 A JP2023126157 A JP 2023126157A JP 2023133505 A5 JP2023133505 A5 JP 2023133505A5
Authority
JP
Japan
Prior art keywords
tcr
seq
cell
amino acid
acid sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023126157A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023133505A (ja
Filing date
Publication date
Priority claimed from PCT/US2019/017708 external-priority patent/WO2019157524A1/en
Application filed filed Critical
Publication of JP2023133505A publication Critical patent/JP2023133505A/ja
Publication of JP2023133505A5 publication Critical patent/JP2023133505A5/ja
Pending legal-status Critical Current

Links

JP2023126157A 2018-02-12 2023-08-02 サイクリンa1特異的t細胞受容体およびその使用 Pending JP2023133505A (ja)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
US201862629648P 2018-02-12 2018-02-12
US62/629,648 2018-02-12
US201862630198P 2018-02-13 2018-02-13
US62/630,198 2018-02-13
US201862667207P 2018-05-04 2018-05-04
US62/667,207 2018-05-04
PCT/US2019/017708 WO2019157524A1 (en) 2018-02-12 2019-02-12 Cyclin a1 specific t cell receptors and uses thereof
JP2020543065A JP2021512637A (ja) 2018-02-12 2019-02-12 サイクリンa1特異的t細胞受容体およびその使用

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2020543065A Division JP2021512637A (ja) 2018-02-12 2019-02-12 サイクリンa1特異的t細胞受容体およびその使用

Publications (2)

Publication Number Publication Date
JP2023133505A JP2023133505A (ja) 2023-09-22
JP2023133505A5 true JP2023133505A5 (https=) 2024-03-01

Family

ID=65767286

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2020543065A Pending JP2021512637A (ja) 2018-02-12 2019-02-12 サイクリンa1特異的t細胞受容体およびその使用
JP2023126157A Pending JP2023133505A (ja) 2018-02-12 2023-08-02 サイクリンa1特異的t細胞受容体およびその使用

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2020543065A Pending JP2021512637A (ja) 2018-02-12 2019-02-12 サイクリンa1特異的t細胞受容体およびその使用

Country Status (11)

Country Link
US (1) US12570712B2 (https=)
EP (1) EP3752525A1 (https=)
JP (2) JP2021512637A (https=)
CN (1) CN112004825A (https=)
AU (1) AU2019218397A1 (https=)
BR (1) BR112020016330A8 (https=)
CA (1) CA3090700A1 (https=)
IL (1) IL276556A (https=)
MX (1) MX2020008403A (https=)
SG (1) SG11202007660UA (https=)
WO (1) WO2019157524A1 (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20220387493A1 (en) * 2019-11-06 2022-12-08 Baylor College Of Medicine Method for producing cytotoxic effector memory t-cells for car t-cell treatment of cancer
CN113321725B (zh) * 2020-02-28 2024-06-11 香雪生命科学技术(广东)有限公司 一种识别afp的t细胞受体
CA3187944A1 (en) 2020-06-22 2021-12-30 Ngm Biopharmaceuticals, Inc. Lair-1-binding agents and methods of use thereof
CN113880953A (zh) * 2020-07-01 2022-01-04 华夏英泰(北京)生物技术有限公司 T细胞抗原受体、其多聚体复合物及其制备方法和应用
CN114057864B (zh) * 2020-07-30 2023-12-15 香雪生命科学技术(广东)有限公司 一种识别afp的高亲和力tcr
KR20230133878A (ko) * 2021-01-19 2023-09-19 우시 바이올로직스 아일랜드 리미티드 안정성 및 발현이 향상된 폴리펩티드 복합체
AU2022256469A1 (en) * 2021-04-14 2023-10-12 Academisch Ziekenhuis Leiden Magec2 immunogenic peptides, binding proteins recognizing magec2 immunogenic peptides, and uses thereof
EP4731758A2 (en) * 2023-06-20 2026-04-29 The Methodist Hospital Antigen-specific t cell receptors and chimeric antigen receptors, and methods of use in immune signaling modulation for cancer immunotherapy
WO2025245169A1 (en) 2024-05-21 2025-11-27 Fred Hutchinson Cancer Center Immunotherapy cells equipped with a collagen-targeting payload

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5283173A (en) 1990-01-24 1994-02-01 The Research Foundation Of State University Of New York System to detect protein-protein interactions
US7067318B2 (en) 1995-06-07 2006-06-27 The Regents Of The University Of Michigan Methods for transfecting T cells
GB9518220D0 (en) 1995-09-06 1995-11-08 Medical Res Council Checkpoint gene
US20020053092A1 (en) 1997-11-14 2002-05-02 Readhead Carol W. Nucleic acid constructs containing a cyclin A1 promoter, and kit
US6461813B2 (en) 1998-09-21 2002-10-08 Rigel Pharmaceuticals, Inc. Multiparameter FACS assays to detect alterations in cell cycle regulation
AU4932199A (en) 1998-07-31 2000-02-21 Haruo Sugiyama Cancer antigens based on tumor suppressor gene wt1 product
US6410319B1 (en) 1998-10-20 2002-06-25 City Of Hope CD20-specific redirected T cells and their use in cellular immunotherapy of CD20+ malignancies
US6946292B2 (en) 2000-10-06 2005-09-20 Kyowa Hakko Kogyo Co., Ltd. Cells producing antibody compositions with increased antibody dependent cytotoxic activity
WO2004024175A1 (ja) 2002-09-12 2004-03-25 Haruo Sugiyama 癌抗原ペプチド製剤
DE10244457A1 (de) 2002-09-24 2004-04-01 Johannes-Gutenberg-Universität Mainz Verfahren zur rationalen Mutagenese von alpha/beta T-Zell Rezeptoren und entsprechend mutierte MDM2-Protein spezifische alpha/beta T-Zell Rezeptoren
PT1731605E (pt) 2004-03-31 2010-04-14 Int Inst Cancer Immunology Inc Péptidos antigénicos de cancro derivados de wt1
JP2008527001A (ja) 2005-01-13 2008-07-24 ザ ジョンズ ホプキンス ユニバーシティー 前立腺幹細胞抗原ワクチンおよびその使用
US7612181B2 (en) 2005-08-19 2009-11-03 Abbott Laboratories Dual variable domain immunoglobulin and uses thereof
US8119772B2 (en) 2006-09-29 2012-02-21 California Institute Of Technology MART-1 T cell receptors
EP2203746B1 (en) 2007-09-24 2013-03-06 Technion Research & Development Foundation Ltd. T cell subpopulations capable of treating cancer
EP2210903A1 (en) 2009-01-21 2010-07-28 Monoclonal Antibodies Therapeutics Anti-CD160 monoclonal antibodies and uses thereof
EP2258719A1 (en) 2009-05-19 2010-12-08 Max-Delbrück-Centrum für Molekulare Medizin (MDC) Multiple target T cell receptor
US8383099B2 (en) 2009-08-28 2013-02-26 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Adoptive cell therapy with young T cells
WO2011091078A2 (en) 2010-01-19 2011-07-28 Xencor, Inc. Antibody fc variants with enhanced complement activity
US20130071414A1 (en) 2011-04-27 2013-03-21 Gianpietro Dotti Engineered cd19-specific t lymphocytes that coexpress il-15 and an inducible caspase-9 based suicide gene for the treatment of b-cell malignancies
US9676854B2 (en) 2011-08-15 2017-06-13 Medimmune, Llc Anti-B7-H4 antibodies and their uses
CN104080797A (zh) * 2011-11-11 2014-10-01 弗雷德哈钦森癌症研究中心 针对癌症的靶向细胞周期蛋白a1的t细胞免疫疗法
BR122020002986A8 (pt) 2012-08-20 2023-04-18 Seattle Childrens Hospital Dba Seattle Childrens Res Inst Método e composições para imunoterapia celular
CA2894879A1 (en) 2012-12-19 2014-06-26 Amplimmune, Inc. B7-h4 specific antibodies, and compositions and methods of use thereof
WO2016040724A1 (en) 2014-09-12 2016-03-17 Genentech, Inc. Anti-b7-h4 antibodies and immunoconjugates
RU2017115315A (ru) 2014-10-03 2018-11-08 Дана-Фарбер Кэнсер Инститьют, Инк. Антитела к рецептору глюкокортикоид-индуцированного фактора некроза опухоли (gitr) и способы их применения
US10317402B2 (en) 2014-12-03 2019-06-11 Verik Bio, Inc. Identification, selection and use of high curative potential T cell epitopes
EP3277294B1 (en) 2015-04-01 2024-05-15 Adaptive Biotechnologies Corp. Method of identifying human compatible t cell receptors specific for an antigenic target
GB201511546D0 (en) 2015-07-01 2015-08-12 Immatics Biotechnologies Gmbh Novel peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers
GB201516272D0 (en) 2015-09-15 2015-10-28 Adaptimmune Ltd And Immunocore Ltd TCR Libraries
GB201604494D0 (en) 2016-03-16 2016-04-27 Immatics Biotechnologies Gmbh Transfected T-Cells and T-Cell receptors for use in immunotherapy against cancers

Similar Documents

Publication Publication Date Title
JP2023133505A5 (https=)
JP2022527635A5 (https=)
Johdi et al. Colorectal cancer immunotherapy: options and strategies
JP7559120B2 (ja) がんに対する免疫療法で使用するための形質移入t細胞およびt細胞受容体
JP7340127B2 (ja) がんに対する免疫療法で使用するための形質移入t細胞およびt細胞受容体
JP2021521776A5 (https=)
JP2021520831A5 (https=)
AR120585A1 (es) Proteínas de unión a antígenos que se unen específicamente a mage-a
JP2019531074A5 (https=)
FI3294333T4 (fi) Klaudiini-18.2-spesifiset immunoreseptorit ja t-soluepitoopit
JP2017523784A5 (https=)
WO2018197492A1 (en) Tcr and peptides
JP2022527267A5 (https=)
JP2022545167A5 (https=)
BR112023022765A2 (pt) Proteínas de ligação ao antígeno que ligam especificamente o prame
JP2020532304A5 (https=)
JP2022523554A5 (https=)
JP2022523552A5 (https=)
JP2024520427A5 (https=)
JP2022524993A5 (https=)
JP2022524994A5 (https=)
JP2022523971A5 (https=)
JP2022523553A5 (https=)
JP2023542528A5 (https=)
JP2022524992A5 (https=)